| Dokumendiregister | Ravimiamet |
| Viit | L-14/4298-2 |
| Registreeritud | 08.11.2023 |
| Sünkroonitud | 19.08.2024 |
| Liik | Sissetulev kiri |
| Funktsioon | L Ravimite kvaliteedi kontrollimine |
| Sari | L-14 Rahvusvaheliste uuringute dokumendid (MRP, CAP, CRS, MSS) |
| Toimik | L-14/2023 |
| Juurdepääsupiirang | AK |
| Juurdepääsupiirang | AvTS § 35 lg 1 p 17 teave, mille avalikustamine võib kahjustada ärisaladust |
| Adressaat | European Directorate for the Quality of Medicines & HealthCare |
| Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
| Vastutaja | Eveli Holst (RA, Labor) |
| Originaal | Ava uues aknas |
| Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
|---|---|---|---|---|---|---|
| Collaborative trial | 16.08.2024 | 3 | L-14/4298-4 🔒 | Sissetulev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |
| Collaborative trial | 16.08.2024 | 3 | L-14/4298-4 🔒 | Sissetulev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |
| Collaborative trial | 09.11.2023 | 284 | L-14/4298-3 🔒 | Väljaminev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |
| Collaborative trial | 09.11.2023 | 284 | L-14/4298-3 🔒 | Väljaminev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |
| Collaborative trial | 08.11.2023 | 285 | L-14/4298-2 🔒 | Sissetulev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |
| Collaborative trial | 25.10.2023 | 299 | L-14/4298-1 🔒 | Sissetulev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |
| Collaborative trial | 25.10.2023 | 299 | L-14/4298-1 🔒 | Sissetulev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |